ANGLE has completed a placing of new ordinary shares
ANGLE Plc has raised funds to develop the company.
ANGLE, through its subsidiaries, engages in providing products in cancer diagnostics and foetal health. Its main product is the Parsortix cell separation system, which can capture very rare cells from the blood. The company was founded by Andrew D. W. Newland in April 1994 and is headquartered in Guildford, UK.
Oaklins Cavendish’s sister firm finnCap, based in the UK, in its role as nominated advisor and joint broker, assisted ANGLE’s management team and shareholders all the way, from the start to the successful completion of the placing. During this process, the team initiated and advised on many aspects, including, among others, securing pre-commitments from cornerstone investors, seeking new institutional investors, deal structuring, document drafting, liaising with the exchange and the placing pricing and sizing.
Talk to the deal team
Managing DirectorLondon, United Kingdom
East West Eye Institute has been acquired by NVISION Eye Centers
East West Eye Institute (EWEI), one of the largest independent eyecare platforms in California, has sold a majority interest to Nvision Eye Centers, one of the larger providers of comprehensive eyecare, LASIK and cataract surgery services in the USA.Learn more
UAB MediCA klinika has acquired UAB Varpo seimos klinika
UAB MediCA klinika has acquired UAB Varpo seimos klinika.Learn more
GBM Resources (ASX:GBZ) has raised US$5.4 million via a placement
GBM Resources Limited has raised funds to accelerate drilling at the flagship Drummond Basin, along with funding the acquisition of Twin Hills.Learn more